BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19435393)

  • 1. Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry.
    Scursoni AM; Galluzzo L; Camarero S; Pozzo N; Gabri MR; de Acosta CM; Vázquez AM; Alonso DF; de Dávila MT
    Pediatr Dev Pathol; 2010; 13(1):18-23. PubMed ID: 19435393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.
    Scursoni AM; Galluzzo L; Camarero S; Lopez J; Lubieniecki F; Sampor C; Segatori VI; Gabri MR; Alonso DF; Chantada G; de Dávila MT
    Clin Dev Immunol; 2011; 2011():245181. PubMed ID: 21941577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
    Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT
    Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
    Hayashi N; Chiba H; Kuronuma K; Go S; Hasegawa Y; Takahashi M; Gasa S; Watanabe A; Hasegawa T; Kuroki Y; Inokuchi J; Takahashi H
    Cancer Sci; 2013 Jan; 104(1):43-7. PubMed ID: 23004020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.
    Furukawa K; Thampoe IJ; Yamaguchi H; Lloyd KO
    J Immunol; 1989 Feb; 142(3):848-54. PubMed ID: 2464027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.
    Carr A; Mullet A; Mazorra Z; Vázquez AM; Alfonso M; Mesa C; Rengifo E; Pérez R; Fernández LE
    Hybridoma; 2000 Jun; 19(3):241-7. PubMed ID: 10952412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
    Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
    Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc.
    Oliva JP; Valdés Z; Casacó A; Pimentel G; González J; Alvarez I; Osorio M; Velazco M; Figueroa M; Ortiz R; Escobar X; Orozco M; Cruz J; Franco S; Díaz M; Roque L; Carr A; Vázquez AM; Mateos C; Rubio MC; Pérez R; Fernández LE
    Breast Cancer Res Treat; 2006 Mar; 96(2):115-21. PubMed ID: 16322892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX2 expression in Wilms tumors and other childhood neoplasms.
    Davis JL; Matsumura L; Weeks DA; Troxell ML
    Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody.
    Talavera A; Eriksson A; Okvist M; López-Requena A; Fernández-Marrero Y; Pérez R; Moreno E; Krengel U
    Mol Immunol; 2009 Oct; 46(16):3466-75. PubMed ID: 19748674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
    Nores GA; Dohi T; Taniguchi M; Hakomori S
    J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
    Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
    Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
    Nishio M; Furukawa K
    Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.
    Gabri MR; Otero LL; Gomez DE; Alonso DF
    J Exp Clin Cancer Res; 2009 Dec; 28(1):146. PubMed ID: 19951433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
    Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ
    Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
    Sehic D; Ciornei CD; Gisselsson D
    Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.